ICON plc - Clinical Research Organisation (CRO) for Drug Development

Webinar: Successful Digital Trial Template

Explore the best practices for implementing a successful digital trial.

Considerations for Parkinson’s Disease Trials

Aspects of Parkinson’s Disease studies that sponsors should bear in mind as they plan their clinical trials.

Increasing site and patient compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

07 November 2018

Managing Clinical Trial Training

Centralising and tracking training requirements for your trials through a learning management system to make it easier for site and study staff.

05 November 2018

Key Considerations for Achieving Digital Trial Success

Digital disruption are emerging to enable pharma and med device companies generate new datasets.

22 October 2018

Improving Responses to Medical Device Vulnerabilities

Discover how manufacturers can improve responses to cybersecurity threats.

10 October 2018

EMA ISO IDMP - The path forward

The EMA is implementing the standards developed by the ISO for the IDMP.

24 September 2018

Simplifying the process of documenting Analysis Results Metadata (ARM)

Automating the process for Define –XML with ARM

18 September 2018

Smart Bioanalytical Strategies in Immuno-Oncology Trials

Discover the latest biomarker-based methods and how they can be leveraged to add value to oncology trials.

29 August 2018

CDISC Legacy Data Conversion

ICON’s Data Management team provides advice and guidance on legacy conversion process and what you need to implement to remain compliant.

27 August 2018

Precision Medicine Opportunities for Device Developers

Medical device developers are emerging into the precision medicine market in a variety of therapeutic areas, including neurology, cardiology and infectious diseases.

01 August 2018

Five Key Considerations for Writing First-in-Human Protocols Under EMA Guidelines

As pharmaceuticals move from animal to first-in-human (FIH) clinical trials, establishing appropriate strategies to minimise risk in early phase clinical trials is necessary.

Services

Therapeutics

Innovation

Insights

News & Events

About ICON

Precision Medicine

Value Based Healthcare

Improving Pharma R&D Efficiency

CDISC Data Standardisation